Address
Email address
Phone number
https://apotheka.eeApotheka e-apteek | Kiire tarne just sinna, kus Sa viibid!Valikus üle 8000 toote - pea nõu apteekriga ja telli ravimid koju kiirkulleriga või tasuta enda lähimasse apteeki. Üle 700 sooduspakkumise. Kiire tarne!
Name
osaühing Pharmal
Registry code
10099034
VAT number
EE100526646
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
16.12.1996 (27)
Financial year
01.01-31.12
Capital
15 720.00 €
Activity
47731 - Dispensing chemist in specialised stores
1 240 382 €
-43 544 €
-4%
2 234 €
(estimate is approximate)
56 078 €
6
Submitted
No tax arrears
-78%
-17%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Maija Tressum 10.05.1952 (72) | 51% - 8 046.00 EUR | Board member | Direct ownership | |
| OÜ Mirrow Institute 10677956 | 49% - 7 674.00 EUR | - | - | |
| Ivar Vendelin 23.05.1975 (49) | - | - | Indirect ownership |
| 2019 02.10.2020 | 2020 22.06.2021 | 2021 15.06.2022 | 2022 21.06.2023 | 2023 18.06.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 1 082 550 € | 1 004 173 € | 1 034 294 € | 1 264 220 € | 1 240 382 € |
| Net profit (loss) for the period | -14 305 € | -16 193 € | -12 262 € | 133 516 € | -43 544 € |
| Profit Margin | -1% | -2% | -1% | 11% | -4% |
| Current Assets | 154 987 € | 132 813 € | 122 784 € | 306 042 € | 248 858 € |
| Fixed Assets | 38 520 € | 40 234 € | 38 589 € | 198 € | 198 € |
| Total Assets | 193 507 € | 173 047 € | 161 373 € | 306 240 € | 249 056 € |
| Current Liabilities | 178 946 € | 174 679 € | 175 267 € | 186 618 € | 192 978 € |
| Non Current Liabilities | 0 € | 0 € | 0 € | 0 € | 0 € |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 14 561 € | -1 632 € | -13 894 € | 119 622 € | 56 078 € |
| Employees | 7 | 7 | 6 | 7 | 6 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 325 055.78 € | 23 138.3 € | 19 003.91 € | 8 |
| 2023 Q4 | 316 773.33 € | 22 714.4 € | 17 986.03 € | 7 |
| 2023 Q3 | 311 591.75 € | 33 353.95 € | 24 037.72 € | 8 |
| 2023 Q2 | 303 249.29 € | 23 050.24 € | 18 959.24 € | 9 |
| 2023 Q1 | 301 563.67 € | 23 929.89 € | 19 582.22 € | 9 |
| 2022 Q4 | 338 516.18 € | 24 179.5 € | 17 449.84 € | 10 |
| 2022 Q3 | 333 091.49 € | 22 849.95 € | 20 255.92 € | 10 |
| 2022 Q2 | 282 050.53 € | 22 082.43 € | 17 454.59 € | 10 |
| 2022 Q1 | 292 991.44 € | 21 311.38 € | 17 102.34 € | 9 |
| 2021 Q4 | 306 026.75 € | 24 231.11 € | 18 134.26 € | 9 |
| 2021 Q3 | 236 752.74 € | 21 356.19 € | 17 105.18 € | 10 |
| 2021 Q2 | 242 178.02 € | 16 766.53 € | 12 489.89 € | 9 |
| 2021 Q1 | 232 715.76 € | 19 481.73 € | 14 893.78 € | 9 |
| 2020 Q4 | 260 893.5 € | 20 289.25 € | 16 617.78 € | 9 |
| 2020 Q3 | 239 361.71 € | 25 276.25 € | 18 650.16 € | 9 |
| 2020 Q2 | 274 480.63 € | 23 115.62 € | 17 044.51 € | 9 |
| 2020 Q1 | 230 557.88 € | 22 530.05 € | 18 947.52 € | 9 |
